21. Mitochondrial disease
23 clinical trials,   29 drugs   (DrugBank: 28 drugs),   44 drug target genes,   65 drug target pathways
Searched query = "Mitochondrial disease"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT01642056 (ClinicalTrials.gov) | September 1, 2012 | 14/7/2012 | EPI-743 for Metabolism or Mitochondrial Disorders | Therapeutic Trial of EPI -743 In Patients With Disorders of Energy Utilization or Oxidation-Reduction | Mitochondrial Disease;Neurology;Myoptahy | Drug: EPI-743;Drug: Placebo | National Human Genome Research Institute (NHGRI) | NULL | Completed | 2 Years | 11 Years | All | 20 | Phase 1;Phase 2 | United States |